PBAC Public Summary Documents - March 2006

Public Summary Documents relating to the March 2006 PBAC Meeting.

Page last updated: 14 July 2006

• Adalimumab, pre-filled syringe, 40 mg per 0.8 mL, Humira®
• Alendronate Sodium with Colecalciferol (vitamin D3), tablet, 70 mg-70 micrograms (2800 i.u.), Fosamax® Plus
• Anecortave acetate, depot suspension, 15 mg in 0.5 mL, Retaane®
• Aprepitant, capsule, 1 x125 mg and 2 x 80 mg Tri - pack, Emend®
• Blood beta-ketone, electrode strips, MediSense Optium® Ketone Blood ?-Ketone Electrodes®
• Bortezomib, powder for I.V. injection, 3.5 mg, Velcade®
• Carmustine, implant, 7.7 mg, Gliadel®
• Docetaxel, injection set containing 1 single use vial concentrate for I.V. infusion, 20 mg (anhydrous) in 0.5 mL and 1 single use vial solvent 1.5 mL and 80 mg (anhydrous) in 2 mL and 1 single use vial solvent 6 mL, Taxotere®
• Epoprostenol Sodium, injection set containing 1 vial powder for I.V. infusion 500 micrograms and 1 vial diluent 50 mL, injection set containing 1 vial powder for I.V. infusion 1.5 mg and 2 vials diluent 50 mL, Flolan®
• Erlotinib hydrochloride, tablet, 25 mg, 100 mg and 150 mg (base), Tarceva®
• Etanercept, injection set containing 4 vials powder for injection 25 mg or 50 mg and 4 pre-filled syringes solvent 1 mL, Enbrel®
• Fentanyl citrate, lozenge with integral applicator, 200 microgram, 400 microgram, 600 microgram, 800 microgram, 1200 microgram and 1600 microgram, Actiq®
• Fentanyl, transdermal patch, releasing approximately 12, 25, 50, 75 or 100 micrograms per hour, Durogesic® 12/25/50/75/100
• Ferrous fumurate with folic acid, tablet, 310 mg – 350 micrograms, Ferro-F-Tab®
• Hylan G-F 20, injection, 16 mg in 2 mL, Synvisc®
• Infliximab, powder for intravenous infusion, 100 mg, Remicade®
• Insulin detemir (rys) cartridge 3mL (Penfill®), prefilled device 3 mL, (FlexPen®), 100 U/mL, Levemir®, March 2006
• Insulin glargine, injection, 100 units per mL, 10 mL vials and 3 mL x 5 cartridges, Lantus®, March 2006
• Methylphenidate hydrochloride, extended release tablets, 18 mg, 36 mg and 54 mg, Concerta®
• Moxonidine, tablets, 200 microgram and 400 microgram, Physiotens®
• Paclitaxel, solution concentrate for I.V. infusion, 30 mg in 5 mL, 100mg in 16.7 mL, 150 mg in 25 mL and 300 mg in 50 mL, Anzatax®
• Pertussis vaccine acellular with Diphtheria and Tetanus Toxoids, adsorbed, injection, 0.5 mL, Adacel®
• Risperidone, powder for I.M. injection, 25 mg, 37.5 mg and 50 mg (modified release) with 2 mL diluent in pre-filled syringe, Risperdal Consta®
• Rituximab, solution for I.V. infusion, 100 mg in 10 mL and 500 mg in 50 mL, Mabthera®
• Ropinirole, tablets, 0.25 mg, 0.5 mg and 2 mg, Repreve®
• Sevelamer hydrochloride, tablets, 800 mg, Renagel®
• Sibutramine hydrochloride, capsules, 10 mg and 15 mg, Reductil/Ectiva®
• Teriparatide, solution for injection, in a 3mL cartridge contained in a pre-filled disposable delivery device (pen), 250 micrograms/mL, Forteo®
• Vinorelbine tartrate, soft capsule, 20 mg and 30 mg (base), Navelbine®